Advising health systems research synthesis: a Q&A
A Commentary published today in Systematic Reviews describes the rationale of an Advisory Group assembled by The Alliance for Health Policy and Systems… Read more »
Ella Flemyng
Journal Development Manager at BioMed Central
Within BMC, Ella oversees a portfolio of open-access, applied-methodology journals within health sciences that aim to improve the design, conduct and reporting of different study designs. She is an advocate for improving research integrity and seeing publishing and peer review develop to meet the needs of the research community. Before working in publishing, Ella completed a Master's of Science in biomedical and molecular science at Kings College London.
Latest posts by Ella Flemyng (see all)
- Patient peer review in academic journals: Next steps in the journey - 10th September 2018
- Increasing diversity in peer review with transparent mentoring of early career researchers - 11th June 2018
- Completed our Clinical Trials Day Quiz? Read about what’s next for clinical trial reporting - 19th May 2017
Podcast: What on earth is the point of doing research if it doesn’t make the patient’s life better?
Following the recent publication of the methods for user involvement in a Cochrane systematic review update in Systematic Reviews, we hear from the authors,… Read more »
What is the single greatest development that will help improve clinical trials? (Part Two)
In our second installment to celebrate International Clinical Trials Day 2015, we hear from a European pharmaceutical company and patients involved in research… Read more »
What is the single greatest development that will help improve clinical trials? (Part One)
To celebrate International Clinical Trials Day 2015, BioMed Central asked a European pharmaceutical company, a funder from the United Kingdom, an Ethiopian… Read more »
A new era for research: Q&A with the Editor-in-Chief of Pilot and Feasibility Studies
Last month marked the highly anticipated launch of our new journal, Pilot and Feasibility Studies, which will address the void left by publication bias against… Read more »
Excuse me Trialist, what are your thoughts?
New research published today in Trials explored the first-hand experiences that trialists face when conducting and reporting clinical trials. What did they say… Read more »
Opinions on systematic review use in policymaking
“There is no such thing as public opinion. There is only published opinion” – Sir Winston Churchill Should systematic reviews be used to inform… Read more »
A movement with momentum – the potential of clinical trials registries
“The registration of all interventional trials is a scientific, ethical and moral responsibility” – World Health Organization (WHO) New research published… Read more »
Research transparency: it’s not a question of if, it’s a question of when and how
On 18 September 2014, following a call for comments from the Health Research Authority (HRA) on their proposals to promote transparency in research, key… Read more »
Another hurdle for researchers from the EMA?
Earlier this week, the European Medicines Agency (EMA) released a draft policy update on access to the data from the EudraVigilance database, which seems to… Read more »